IP 173 Pill - orange rectangle, 10mm
Pill with imprint IP 173 is Orange, Rectangle and has been identified as Memantine Hydrochloride 5 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.
Memantine is used in the treatment of Alzheimer's Disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IP 173
Memantine Hydrochloride
- Imprint
- IP 173
- Strength
- 5 mg
- Color
- Orange
- Size
- 10.00 mm
- Shape
- Rectangle
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals of New York, LLC
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
magnesium silicate,
D&C Yellow No. 10,
FD&C Blue No. 2,
FD&C Yellow No. 6,
polyethylene glycol,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 42291-0551 (Discontinued) | AvKare, Inc. |
| 53746-0173 | Amneal Pharmaceuticals LLC |
Related images for "IP 173"
More about memantine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (108)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous central nervous system agents
- En español
Patient resources
Other brands
Professional resources
- Memantine monograph
- Memantine (FDA)
- Memantine ER Tablets (FDA)
- Memantine ER capsules (FDA)
- Memantine Oral Solution (FDA)
- Memantine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.